News

EP PerMed Call 2027 opening soon: Cell and Gene Therapy for Personalised Medicine

Published on | 1 hour ago

Programmes
Health Missions

The European Partnership for Personalised Medicine (EP PerMed) is about to launch the joint transnational call 2027 (JTC2027) “Cell and Gene Therapy for Personalised Medicine”. The call opens on 4 November 2026.

Proposals must focus on the development and validation of an innovative and novel cell and gene therapy for personalised medicine.

The call aims to fund multinational, innovative research projects in personalised medicine, which should bring together academic, clinical/public health and private research teams. The JTC2027 will be conducted simultaneously by the participating funding organisations in their respective region/country and coordinated centrally by the Joint Call Secretariat. The call will be implemented in two stages.

Research Foundation Flanders (FWO) plans to participate in this call. More information on available funding for researchers based in Flanders and on how to apply will become available on the FWO website upon launch of the call. Deadline for the submission of pre-proposals is 20 January 2027. Questions on available funding by FWO? Contact europe@fwo.be.

All detailed information about the call and how to apply is available on the EP PerMed dedicated webpage. A partnering tool is also available. Interested in applying? Join the information webinar on 3 December 2026 here.

myOverview - sign up for personalised information

We offer news and event updates, covering all domains and topics of Horizon Europe, Digital Europe & EDF (and occasionally, for ongoing projects, Horizon 2020).

Stay informed about what matters to you. By signing up, you can opt in for e-mail notifications and get access to a personalised dashboard that groups all news updates and event announcements in your domain(s).

Only for stakeholders located in Flanders

Latest News

2043 articles available search in articles 

Testimonial

image of CLARION: Port of Antwerp-Bruges participates in research contributing to shaping a sustainable future for the maritime sector

CLARION: Port of Antwerp-Bruges participates in research contributing to shaping a sustainable future for the maritime sector

Funded under Horizon Europe (HORIZON-CL5-2023-D6-01-09), running from 2024 to 2028, CLARION (Building Climate-Resilient Ports for the Future) aims to contribute to shaping a sustainable future for the maritime sector by developing and implementing innovative climate adaptation solutions. Port of Antwerp-Bruges is one of the leading European ports involved in the project. Together with two other Flemish project partners, Brabo Group and the Antwerp Maritime Academy, Port of Antwerp-Bruges is developing demo cases that tackle real-life operational and training challenges posed by climate risks. Read more about the project in this testimonial.